Aceto Corp (ACET) is Trading Lower on Unusual Volume for February 05

Equities Staff |

Aceto Corp (ACET) experienced unusually high volume on Feb. 05, as the stock lost 10.01% to a closing price of $20.68. The stock saw 343,046 shares trade hands over the course of the day on 2,501 trades. Given that the stock’s average daily volume over the last month has been 217,327 shares a day, this represents a pretty substantial spike over the norm.

Aceto Corp has a P/B ratio of 2.3. It also has a P/E ratio of 17.8. The stock has traded between $32.20 and $18.03 over the last 52-weeks, its 50-day SMA is now $25.25, and its 200-day SMA $25.11.

Aceto Corp is engaged in the marketing, sells and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, and specialty performance chemicals.

Headquartered in Port Washington, NY, Aceto Corp has 270 employees and is currently under the leadership of CEO Salvatore J. Guccione.

For a complete fundamental analysis analysis of Aceto Corp, check out’s Stock Valuation Analysis report for ACET. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.


Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…